NPR

Studies suggest sharp drop in vaccine protection v. omicron — yet cause for optimism

In small studies in South Africa and Germany, the results indicate a marked decrease in the ability of vaccines to neutralize this variant. But there are other findings that are encouraging.

With the omicron variant continuing to spread in a number of countries, including the U.S, scientists have been anxiously awaiting data to answer this question: How well will the vaccines work against this new variant?

On Tuesday night and Wednesday morning, scientists in South Africa and Germany released preliminary results from two small studies that begin to provide answers.

The studies haven't been peer reviewed. also indicates that a third shot, or a booster, will partially recover the effectiveness of the vaccines, at least for a few months.

You’re reading a preview, subscribe to read more.

More from NPR

NPR2 min read
Peloton Is Laying Off Workers And Replacing The CEO — Again
It's déjà vu for the luxury fitness company: Peloton is cutting about 400 more jobs, and its CEO is stepping down just two years after a major shakeup.
NPR7 min readAmerican Government
Trump Trial Coverage
The news media face a number of temptations while covering the criminal trial of former President Donald Trump, including dwelling on salacious details, overdramatizing insignificant moments, and getting distracted by out-of-court behaviors that have
NPR1 min readAmerican Government
FTC Bars Former Pioneer CEO In Exxon Mobil Deal, Saying He Colluded With OPEC
Exxon Mobil's $60 billion deal to buy Pioneer Natural Resources received federal clearance, but former Pioneer CEO Scott Sheffield was barred from joining the new company's board of directors.

Related Books & Audiobooks